Stay updated on IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.

Latest updates to the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference4%
- Check21 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check29 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check36 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check43 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
- Check72 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
Stay in the know with updates to IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.